Less than half of VA hospitals are sites for prostate cancer clinical trials. Patients who are transgender and gender nonconforming with genitourinary and gynecologic cancers face inequalities in care. Enrollment falls short by approximately one in 14 women with kidney cancer. Colorectal cancer screening was higher among patients who had accessed their online medical records. Non-Hispanic Black women have worse breast cancer outcomes compared to White women. Research has linked TCE exposure to liver and kidney cancers, non-Hodgkin’s lymphoma Black patients were less likely to receive resection compared with White patients. Area Deprivation Index was associated with overall survival in both Black and Hispanic patients. Prostate-specific antigen (PSA) velocity and PSA values taken together may improve the specificity of monitoring. Patients and survivors who engaged in physical activity experienced a protective effect on mental health. Contaminants, such as heavy metals, pesticides, and microbial pathogens, may influence cancer severity. Patients and caregivers most valued the role of genetics in understanding risk stratification. Black, Hispanic, and Asian patients were underrepresented in trials compared with national lymphoma data. Black women experience more frequent delays through the breast cancer care continuum. In lower-income countries, intravesical therapies for bladder cancer can match or exceed median household incomes. Women had an 89% match rate in urologic oncology fellowships, compared with 54% in men. The rate of prostate cancer mortality is higher in parts of the United States where structural racism is also higher. The slower recovery PSA screening rate in Black men highlights the persistent racial disparities in health care access. Families reported the direct cash support program offered them the “ability to spend more time at their child’s ... Despite delays to infusion, response rates to CAR-T were comparable across racial groups.